1.1Direct leaflet edge coupling
Paired grippers capture the opposing leaflet edges, and a latch holds the clip arms closed. During systole, the leaflet tissue on either side of the clip comes into contact and reduces the regurgitant opening.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
Paired grippers capture the opposing leaflet edges, and a latch holds the clip arms closed. During systole, the leaflet tissue on either side of the clip comes into contact and reduces the regurgitant opening.
Circumferential sutures secure a contoured ring to a dilated mitral annulus. The ring reduces the anteroposterior dimension and brings the leaflet attachment lines closer together, increasing leaflet overlap during systole.
A torque shaft rotates the screw into ventricular myocardium while the screw retains its diameter. A tether runs from the screw to the spacer, and a mechanical lock sets the tether length to hold the spacer at the leaflet closure plane.
The frame supports the guide rail, and two collars on the rail straddle the leaflet closure plane. A central bore lets the spacer slide between the collars, whose spacing limits axial travel and keeps the spacer in the leaflet closure region.
The capsule wall holds the compressed distal frame by radial contact while a proximal coupling on a stationary pusher maintains axial position. Capsule withdrawal exposes the distal frame, and stored elastic strain in the frame produces radial expansion.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A silicone spacer extends through a two-flap check valve in a water recirculation line and presents a closing surface to both flaps. The spacer attaches to an expandable anchor housed in the downstream valve chamber. A service tool grips the anchor's proximal connector with an outer tube and its distal connector with an inner rod. The tube advances as the rod retracts, shortening the anchor until it expands into a groove in the chamber wall.
A laser-cut nitinol tube forms the expandable anchor, with six outward-curved struts between two uncut end rings. The proximal and distal rings carry connectors for an outer delivery tube and an inner pull rod, respectively. Opposite axial motion brings the rings together and bows the struts outward. A ratchet sleeve between the rings holds their axial separation after the delivery elements detach, and a stem from the distal ring supports the spacer across the valve.
A thermoplastic polyurethane bladder replaces the solid spacer body and mounts on a support stem attached to the expandable anchor. Internal tethers join the two broad bladder walls and limit their separation so the inflated bladder presents broad faces to the leaflets. A fill lumen in the delivery catheter supplies saline through a self-sealing valve at the proximal end of the bladder while the anchor remains collapsed. After filling and positioning the spacer, the operator advances the outer tube and retracts the inner rod to expand the anchor, then withdraws the fill cannula to seal the bladder.
Three bench test assemblies use silicone spacers with elliptical cross sections measuring 6 × 8 mm, 8 × 10 mm, and 10 × 12 mm, each with a 20 mm working length. Each spacer attaches to an anchor with a 30 mm deployed diameter and mounts across the same two-leaflet valve model. An outer tube advances 3 mm while an inner rod retracts 3 mm to shorten the anchor between its end connectors and seat it in the model chamber. The pulse duplicator cycles the valve at 70 cycles per minute and measures reverse flow for each spacer size.
Two thin echogenic bands sit beneath the spacer jacket at the ends of its leaflet-contact region, and small echogenic sleeves mark the widest part of the anchor. A separate intracardiac ultrasound catheter images the bands and sleeves during delivery. The operator aligns the marked region with the valve leaflets, then advances the outer delivery tube and retracts the inner rod to expand the anchor. A transverse ultrasound view shows the expanded anchor relative to the chamber wall before the delivery connectors detach.
Two motorized lead-screw stages mount on the delivery handle and attach separately to the outer tube and inner rod that engage the anchor connectors. Linear encoders measure stage travel, and inline load cells measure axial force in each delivery element. After the operator positions the spacer and commands deployment, the controller advances the tube and retracts the rod in synchronized increments. The controller stops both stages when either load channel reaches its configured limit or the encoder readings reach the programmed end positions.
A compressible polyurethane foam core sits inside a thin woven polyester sleeve. The deployed core presents a rounded surface against which the native leaflets close during systole.
A molded silicone body has an oval cross section with its long axis aligned along the leaflet closure line. Rounded lateral faces provide contact surfaces for the opposing leaflets, and a central lumen accepts a support shaft.
Nickel titanium wires form a tubular braid with crimped end collars that couple to the delivery shafts. The proximal shaft advances as the distal shaft retracts, shortening the braid and increasing its diameter.
The proximal and distal anchor hubs each contain a threaded socket that engages a matching delivery shaft tip. The shafts move axially toward one another to expand the anchor, then rotate relative to the hubs to disengage the tips.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
The valve body will be disposed between the native leaflets to close the gap caused by mal-coaptation of the native leaflets by providing a surface for at least one of the native leaflets to coapt against, while effectively replacing a second native leaflet in the area of the valve which, were it functioning normally, it would occlude during systole.A · US 10,376,365 B2 · ¶ 63
The valve body will be disposed between the native leaflets to close the gap caused by mal-coaptation of the native leaflets by providing a surface for at least one of the native leaflets to coapt against, while effectively replacing a second native leaflet in the area of the valve which, were it functioning normally, it would occlude during systole.B · US 11,419,722 B2 · ¶ 58
Some methods comprise selectively deploying a first anchor into heart tissue distal to the annulus, selectively deploying a second anchor proximal to the annulus near a mid-point of the annular edge of the second leaflet, and coupling the first anchor and the second anchor to a coaptation assist body comprising a coaptation surface and a leaflet surface such that the coaptation assist body is suspended across the valve plane from the atrium proximally to the ventricle distallB · US 11,419,722 B2 · ¶ 24
An empty cell means only that no passage was reproduced there.
Embodiments include implants for treatment of mitral valve regurgitation.A · US 10,376,365 B2 · ¶ 3
Failure of the leaflets to seal during ventricular systole is known as malcoaptation, and may allow blood to flow backward through the valve (regurgitation).A · US 10,376,365 B2 · ¶ 9
Embodiments of the invention include implants for treatment of mitral valve regurgitation.B · US 11,419,722 B2 · ¶ 2
Unfortunately, the AV valves may become damaged or may otherwise fail to function properly, resulting in improper closing.B · US 11,419,722 B2 · ¶ 8
patent.fyi, US 2026/0354974 A1, claim 1, first published 2026-11-19T06:40:31-05:00, https://patent.fyi/US20260354974/, SHA-256 765b4d274e1b9e4300bdebe721781d4c1cf066b89deec93fcab1ce0c4e2d2958